Clinical Trial: Booster Study of SpikoGen COVID-19 Vaccine
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: Immunogenicity and Safety Study in Ambulatory Adults of a Single Intramuscular Dose of SpikoGen Vaccine as a Heterologous or Homologous Booster Dose Following Completion of a Primary Course of Covid-1
Brief Summary:
The purpose of the study is to assess the effectiveness of Spikogen vaccine when used as a 3rd or 4th dose booster in adults who have been previously vaccinated with any Covid-19 vaccine types, including mRNA vaccine, adenoviral vector vaccines, recombinant protein vaccines, or inactivated virus vaccines.
Read more